ReviewNuclear medicine and molecular imaging2018

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors.

Keunyoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.